May 6 (Reuters) - Takeda Pharmaceutical Co Ltd 4502.T :
* SKYHAWK THERAPEUTICS ANNOUNCES AGREEMENT WITH TAKEDA TO DEVELOP NOVEL SMALL MOLECULE RNA SPLICING MODIFIERS FOR NEURODEGENERATIVE DISEASES
May 6 (Reuters) - Takeda Pharmaceutical Co Ltd 4502.T :
* SKYHAWK THERAPEUTICS ANNOUNCES AGREEMENT WITH TAKEDA TO DEVELOP NOVEL SMALL MOLECULE RNA SPLICING MODIFIERS FOR NEURODEGENERATIVE DISEASES